Article R4451-127
The Institut de Radioprotection et de Sûreté Nucléaire is responsible for: 1° Managing the information and monitoring system for exposure to ionising radiation and organising the access required to ap…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 2351–2360 of 5385 articles for “Art. 13 Nov 2008”
The Institut de Radioprotection et de Sûreté Nucléaire is responsible for: 1° Managing the information and monitoring system for exposure to ionising radiation and organising the access required to ap…
A joint order of the ministers responsible for labour, radiation protection and agriculture shall determine: 1° With regard to the competent person in charge of radiation protection: a) The content an…
To be designated as a radiation protection advisor, the following is required: 1° For the person competent in radiation protection, a training certificate issued by a training body certified by a cert…
When, in the light of the results of individual dosimetric monitoring, the exposure of a worker has exceeded one of the dose limit values set in Article R. 4451-6, the Institut de Radioprotection et d…
As part of the pharmacovigilance system, any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 : 1° Implements a risk management system for each medi…
For the medicinal products mentioned in 1° of II of article L. 5121-12 and in II of article L. 5121-12-1, the obligations set out in article R. 5121-161 and articles R. 5121-166 to R. 5121-170 are car…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 shall implement a pharmacovigilance system in order to fulfil its pharmacovigilance obligations…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 is required to: 1° Record all adverse reactions suspected of being due to a medicinal product o…
…he drug dependence and addictovigilance assessment and information centres mentioned in Article R. 5132-112 are responded to fully and promptly;7° Provide the Director General of the Agence nationale…
The holder of the authorisation provided for in Article L. 4211-6 is required to report the following to the Director General of the Agence nationale de sécurité du médicament et des produits de santé…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More